| Primary |
| Asthma |
40.0% |
| Dyspepsia |
40.0% |
| Chronic Obstructive Pulmonary Disease |
20.0% |
|
| Lower Respiratory Tract Infection |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
16.7% |
| Gastrooesophageal Reflux Disease |
16.7% |
| Osteoporosis |
16.7% |
| Abdominal Pain |
8.3% |
| Cough |
8.3% |
| Hypertension |
8.3% |
| Hypertonic Bladder |
8.3% |
| Irritable Bowel Syndrome |
8.3% |
| Sleep Disorder |
8.3% |
|
| Completed Suicide |
18.2% |
| Vomiting |
18.2% |
| Abdominal Pain Upper |
9.1% |
| Dyspepsia |
9.1% |
| Gastric Ulcer Haemorrhage |
9.1% |
| Nausea |
9.1% |
| Pain In Extremity |
9.1% |
| Therapeutic Response Decreased |
9.1% |
| Weight Decreased |
9.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.7% |
| Product Used For Unknown Indication |
11.8% |
| Depression |
9.2% |
| Convulsion |
7.1% |
| Pain |
5.4% |
| Rheumatoid Arthritis |
5.4% |
| Non-small Cell Lung Cancer |
4.5% |
| Gastrooesophageal Reflux Disease |
4.2% |
| Smoking Cessation Therapy |
3.1% |
| Hypertension |
2.8% |
| Osteoporosis |
2.8% |
| Anxiety |
2.4% |
| Breast Cancer |
2.4% |
| Cardiac Disorder |
2.4% |
| Ear Infection |
2.1% |
| Epilepsy |
2.1% |
| Sleep Disorder |
2.1% |
| Blood Cholesterol Increased |
1.9% |
| Dyspepsia |
1.9% |
| Multiple Sclerosis |
1.9% |
|
| Vomiting |
12.5% |
| Weight Increased |
12.5% |
| Ventricular Septal Defect |
9.4% |
| Nausea |
8.6% |
| Somnolence |
7.0% |
| Weight Decreased |
7.0% |
| Drug Ineffective |
6.3% |
| Pharmaceutical Product Complaint |
4.7% |
| Malaise |
3.9% |
| Urticaria |
3.9% |
| Rash |
3.1% |
| Dyspepsia |
2.3% |
| Herpes Zoster |
2.3% |
| Neutropenia |
2.3% |
| Osteoporosis |
2.3% |
| Pain In Extremity |
2.3% |
| Palpitations |
2.3% |
| Pancreatitis |
2.3% |
| Pulmonary Embolism |
2.3% |
| Tremor |
2.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Drug Interaction |
50.0% |
| Therapeutic Response Decreased |
50.0% |
|
